Evidence map›Paper›PMID 16820097›Full record

ArticleNeoplasia (New York, N.Y.)2006

Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model.

Uddhav P Kelavkar, Anil V Parwani, Scott B Shappell, W David Martin

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Lipoxygenases at the Intersection of Infection and Carcinogenesis.International journal of molecular sciences · 2024
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Mammalian lipoxygenases and their biological relevance.Biochimica et biophysica acta · 2015
    Review
  9. Drug discovery in prostate cancer mouse models.Expert opinion on drug discovery · 2015
    Review
  10. Article
  11. Article
  12. Article
  13. Arachidonic acid metabolism in human prostate cancer.International journal of oncology · 2012
    Article
  14. Article
  15. Article
  16. Article
  17. Mouse models of prostate cancer.Prostate cancer · 2011
    Article
  18. Article
  19. Article
  20. Neoplasia: the second decade.Neoplasia (New York, N.Y.) · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Uddhav P KelavkarDepartment of Urology and Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA. kelavkarup@upmc.edu
Anil V Parwani
Scott B Shappell
W David Martin
Emory University · USMolecular Oncology (United States) · USUniversity of Pittsburgh · USUPMC Hillman Cancer Center · US

Funding

Prostate Cancer: A Mouse Model Testing 15-Lipoxygenase-1R21CA098657 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KELAVKAR, UDDHAV P · 2003 to 2004
$296k
NCI NIH HHS R21 CA098657NCI NIH HHS R21-CA098657-02
6 · The paper itself

Abstract

The incidence and mortality of prostate cancer (PCa) vary greatly in different geographic regions, for which lifestyle factors, such as dietary fat intake, have been implicated. Human 15-lipoxygenase-1 (h15-LO-1), which metabolizes polyunsaturated fatty acids, is a highly regulated, tissue-specific, lipid-peroxidating enzyme that functions in physiological membrane remodeling and in the pathogenesis of atherosclerosis, inflammation, and carcinogenesis. We have shown that aberrant overexpression of 15-LO-1 occurs in human PCa, particularly high-grade PCa, and in high-grade prostatic intraepithelial neoplasia (HGPIN), and that the murine orthologue is increased in SV40-based genetically engineered mouse (GEM) models of PCa, such as LADY and TRansgenic Adenocarcinoma of Mouse Prostate. To further define the role of 15-LO-1 in prostate carcinogenesis, we established a novel GEM model with targeted overexpression of h15-LO-1 in the prostate [human fifteen lipoxygenase-1 in mouse prostate (FLiMP)]. We used a Cre- mediated and a loxP-mediated recombination strategy to target h15-LO-1 specifically to the prostate of C57BL/6 mice. Wild-type (wt), FLiMP+/-, and FLiMP+/+ mice aged 7 to 21, 24 to 28, and 35 weeks were characterized by histopathology, immunohistochemistry (IHC), and DNA/RNA and enzyme analyses. Compared to wt mice, h15-LO-1 enzyme activity was increased similarly in both homozygous FLiMP+/+ and hemizygous FLiMP+/- prostates. Dorsolateral and ventral prostates of FLiMP mice showed focal and progressive epithelial hyperplasia with nuclear atypia, indicative of the definition of mouse prostatic intraepithelial neoplasia (mPIN) according to the National Cancer Institute. These foci showed increased proliferation by Ki-67 IHC. No progression to invasive PCa was noted up to 35 weeks. By IHC, h15-LO-1 expression was limited to luminal epithelial cells, with increased expression in mPIN foci (similar to human HGPIN). In summary, targeted overexpression of h15-LO-1 (a gene overexpressed in human PCa and HGPIN) to mouse prostate is sufficient to promote epithelial proliferation and mPIN development. These results support 15-LO-1 as having a role in prostate tumor initiation and as an early target for dietary or other prevention strategies. The FLiMP mouse model should also be useful in crosses with other GEM models to further define the combinations of molecular alterations necessary for PCa progression.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsArachidonate 15-LipoxygenaseDisease Models, AnimalDisease ProgressionHumansKi-67 AntigenMaleMiceMice, Inbred C57BLMice, TransgenicProstateProstatic Intraepithelial NeoplasiaProstatic NeoplasmsArachidonate 15-LipoxygenaseKi-67 Antigen

Identifiers

PMID16820097
PMCPMC1601466
OpenAlexW1972661569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.